NDC11 24201015001
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 24201-0150-01 | 24201-0150 |
| 24201-0150-1 | 24201-0150 |
| 24201-150-01 | 24201-150 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Medroxyprogesterone Acetate Injectable Suspension | MEDROXYPROGESTERONE ACETATE | Hikma Pharmaceuticals USA Inc. | 0476eac5-d96c-4910-aa86-1ddeeefefe50 | 2025-01-08 | Boxed warning, Warnings, Adverse reactions | 24201-150-01 24201-150 24201015001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.